Cargando…
IL-36 signalling enhances a pro-tumorigenic phenotype in colon cancer cells with cancer cell growth restricted by administration of the IL-36R antagonist
The IL-36 cytokines are a recently described subset of the IL-1 family of cytokines, shown to play a role in the pathogenesis of intestinal diseases such as Inflammatory Bowel Disease (IBD). Given the link between IBD and colitis –associated cancer, as well as the involvement of other IL-1 family me...
Autores principales: | Baker, Kevin, O’Donnell, Charlotte, Bendix, Maura, Keogh, Samuel, Byrne, James, O’Riordain, Michael, Neary, Peter, Houston, Aileen, Brint, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076531/ https://www.ncbi.nlm.nih.gov/pubmed/35365751 http://dx.doi.org/10.1038/s41388-022-02281-2 |
Ejemplares similares
-
An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer
por: O'Donnell, Charlotte, et al.
Publicado: (2016) -
IL-36 cytokines in inflammatory and malignant diseases: not the new kid on the block anymore
por: Byrne, James, et al.
Publicado: (2021) -
Altered serum levels of IL-36 cytokines (IL-36α, IL-36β, IL-36γ, and IL-36Ra) and their potential roles in Guillain-Barré syndrome
por: Zhao, Zhikang, et al.
Publicado: (2020) -
IL-1 Family Members in Cancer; Two Sides to Every Story
por: Baker, Kevin J., et al.
Publicado: (2019) -
The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis
por: Madonna, Stefania, et al.
Publicado: (2019)